Cost-sharing of 0%, 10%, 20%, 50% of basic cost of subsidised medicines and medical supplies for outpatient treatment, depending on diagnosed with diseases, syndromes and conditions specified in the list of diseases and subsidised medicines to cure them or in the list of subsidised medical supplies by level of compensation. Any difference between retail price and Òreference priceÓ for products subject to reference pricing (about 5% of drugs dispensed) is paid by the patient.